Stockscreener 앱 받기
123.90
0.06%
0.07
전일 마감가:
$123.83
열려 있는:
$123.89
하루 거래량:
2.06M
Relative Volume:
0.97
시가총액:
$9.80B
수익:
-
순이익/손실:
$-450.07M
주가수익비율:
-20.45
EPS:
-6.0583
순현금흐름:
$-312.79M
1주 성능:
+0.14%
1개월 성능:
+0.45%
6개월 성능:
+17.94%
1년 성능:
+50.97%
1일 변동 폭
$123.85
$123.91
1주일 범위
$123.55
$123.91
52주 변동 폭
$71.13
$123.91
Nuvalent Inc Stock (NUVL) Company Profile
명칭
Nuvalent Inc
전화
508-446-2272
주소
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
Compare NUVL vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NUVL
Nuvalent Inc
|
123.90 | 9.80B | 0 | -450.07M | -312.79M | -6.0583 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Nuvalent Inc Stock (NUVL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-30 | 개시 | Wells Fargo | Overweight |
| 2025-11-24 | 개시 | Truist | Buy |
| 2025-11-12 | 개시 | Canaccord Genuity | Buy |
| 2025-10-16 | 재개 | Stifel | Buy |
| 2025-10-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-09-04 | 재개 | Guggenheim | Buy |
| 2025-09-03 | 개시 | Raymond James | Outperform |
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2025-03-14 | 업그레이드 | UBS | Neutral → Buy |
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-10-24 | 개시 | UBS | Neutral |
| 2024-08-29 | 개시 | Barclays | Overweight |
| 2024-04-17 | 개시 | Jefferies | Buy |
| 2024-04-01 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-02-28 | 재개 | Guggenheim | Buy |
| 2024-02-23 | 개시 | Robert W. Baird | Outperform |
| 2023-09-27 | 개시 | Stifel | Buy |
| 2023-08-08 | 개시 | SVB Securities | Market Perform |
| 2023-07-24 | 개시 | Guggenheim | Buy |
| 2023-01-18 | 개시 | Wedbush | Outperform |
| 2022-06-24 | 개시 | BMO Capital Markets | Outperform |
모두보기
Nuvalent Inc 주식(NUVL)의 최신 뉴스
Nuvalent stock hits all-time high at $123.91 By Investing.com - Investing.com India
Nuvalent CSO Henry Pelish sells $261,362 in stock - Investing.com
Nuvalent (NUVL) CSO Pelish sells 2,111 shares in tax-related 10b5-1 trade - Stock Titan
Form 4 Nuvalent Inc For: 10 July By Investing.com - Investing.com Canada
GSK-Nuvalent merger waiting period expires in the US (correct*) - MLex
Nuvalent Inc. (NUVL) — GSK’s Harmony Row clears HSR; $124 cash offer proceeds - Stock Titan
Nuvalent, Inc. (NUVL) — HSR waiting period cleared; $124/ share cash offer remains subject to closing conditions - Stock Titan
Form 144 NUVALENT For: 9 July By Investing.com - Investing.com Nigeria
NUVL (NASDAQ: NUVL) insider sale notice for 2,111 Class A shares - Stock Titan
GSK: Is This FTSE 100 Pharma Stock Making a Comeback? - Morningstar
How Nuvalent Inc. (NUVL) Affects Rotational Strategy Timing - Stock Traders Daily
Nuvalent president and CEO Porter sells $3.7m in shares By Investing.com - Investing.com Australia
Nuvalent(NUVL.US) Officer Sells US$3.71 Million in Common Stock - Moomoo
Form 4 Nuvalent Inc For: 8 July By Investing.com - Investing.com Nigeria
Nuvalent president and CEO Porter sells $3.7m in shares - Investing.com
Nuvalent (NUVL) CEO executes 30K-share option exercise and open-market sale under 10b5-1 plan - Stock Titan
FMR LLC discloses 1,417,590 shares in Nuvalent (NASDAQ: NUVL) - Stock Titan
Nuvalent Announces Closing of Upsized Public Offering of Common Stock - GuruFocus
GSK (NYSE: GSK) makes $124 cash tender offer for Nuvalent (NUVL) shares - Stock Titan
Nuvalent (NUVL) supplements disclosures as $124 cash offer proceeds - Stock Titan
Form 4 Nuvalent Inc For: 6 July By Investing.com - Investing.com Nigeria
Nuvalent chief development officer Noci sells $2.84m in stock By Investing.com - Investing.com South Africa
Nuvalent chief development officer Noci sells $2.84m in stock - Investing.com
Nuvalent (NUVL) CDO exercises options and sells 23,000 shares - Stock Titan
Nuvalent (NUVL) CFO sells 11,430 shares and exercises options under plan - Stock Titan
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Nuvalent, Inc. (NUVL) Stock Analysis: Unpacking the $9.79 Billion Market Cap and Future Potential - DirectorsTalk Interviews
GSK acquires Nuvalent for $10.6 billion in oncology push - qz.com
Enterprise value to revenue forward of Nuvalent, Inc. – NASDAQ:NUVL - TradingView
Price to earnings forward of Nuvalent, Inc. – NASDAQ:NUVL - TradingView
NUVL News | NUVALENT INC-A (NASDAQ:NUVL) - ChartMill
Nuvalent Inc stock hits all-time high at 123.7 USD - Investing.com
Nuvalent Inc stock hits all-time high at 123.7 USD By Investing.com - Investing.com South Africa
Shareholder Alert: Ademi LLP investigates whether Nuvalent, Inc. is obtaining a Fair Price for Public Shareholders - GlobeNewswire
Nuvalent, Inc. (NASDAQ:NUVL) Short Interest Update - MarketBeat
NUVL (NASDAQ: NUVL) Form 144 lists insider sale of Class A Common - Stock Titan
Insider at Nuvalent (NUVL) exercises options and sells 5,500 shares - Stock Titan
GSK agrees to acquire Nuvalent, Inc. - Pennsylvania Business Report -
Halper Sadeh LLC is Investigating Whether LCII, NUVL, DAN, TMHC are Obtaining Fair Deals for their Shareholders - GlobeNewswire
Halper Sadeh LLC is Investigating Whether LCII, NUVL, DAN, TMHC are Obtaining Fair Deals for their Shareholders - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nuvalent, Inc. (Nasdaq – NUVL), Dana Incorporated (NYSE – DAN), SUNation Energy, Inc. (Nasdaq – SUNE), Taylor Morrison Home Corporation (NYSETMH - GlobeNewswire
GSK plc (GSK) Launches Tender Offer to Acquire Nuvalent Inc. for $124 Per Share - Insider Monkey
GSK ends £2bn buyback with shares near 2,000p; Nuvalent deal in focus - Bez Kabli
GSK trades close to analyst target after Nuvalent deal - Bez Kabli
Nuvalent, Inc.(NasdaqGS: NUVL) added to Russell 2000 Growth-Defensive Index - marketscreener.com
Nuvalent, Inc.(NasdaqGS: NUVL) added to Russell 2000 Defensive Index - marketscreener.com
(NUVL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
GSK plc (LON:GSK) share price: 3% weekly gain puts Nuvalent tender deadline in view - Bez Kabli
GSK launches $124-a-share takeover bid for cancer biotech Nuvalent - Indian Pharma Post
GSK announces Nuvalent tender offer, shares supported by oncology push - Ad-hoc-news.de
Enterprise value to EBIT forward of Nuvalent, Inc. – NASDAQ:NUVL - TradingView
Nuvalent Inc (NUVL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.64%
자본화:
|
볼륨(24시간):